癌症研究
封锁
免疫疗法
肺癌
PD-L1
癌症
内科学
肿瘤科
医学
受体
作者
Eri Sugiyama,Yosuke Togashi,Yoshiko Takeuchi,Sayoko Shinya,Yasuko Tada,Keisuke Kataoka,Kenta Tane,Eiichi Sato,Genichiro Ishii,Kōichi Goto,Yasushi Shintani,Meinoshin Okumura,Masahiro Tsuboi,Hiroyoshi Nishikawa
出处
期刊:Science immunology
[American Association for the Advancement of Science (AAAS)]
日期:2020-01-03
卷期号:5 (43)
被引量:180
标识
DOI:10.1126/sciimmunol.aav3937
摘要
EGFR inhibitor erlotinib synergizes with anti–PD-1 in a mouse model of lung adenocarcinoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI